Olaparib for metastatic breast cancer in a patient with a germline PALB2 variant

Por Kuemmel, Sherko, Harrach, Hakima, Schmutzler, Rita K., Kostara, Athina, Ziegler-Löhr, Katja, Dyson, Mark H., Chiari, Ouafaa, Reinisch, Mattea
Publicado no NPJ Breast Cancer (2020)

Clinical utility of genomic signatures in young breast cancer patients: a systematic review

Por Villarreal-Garza, Cynthia, Ferrigno, Ana S., De la Garza-Ramos, Cynthia, Barragan-Carrillo, Regina, Lambertini, Matteo, Azim, Hatem A.
Publicado no NPJ Breast Cancer (2020)

Disparities in contralateral prophylactic mastectomy use among women with early-stage breast cancer

Por Kim, Younji, McCarthy, Anne Marie, Bristol, Mirar, Armstrong, Katrina
Publicado no NPJ Breast Cancer (2017)

TNF is a key cytokine mediating neutrophil cytotoxic activity in breast cancer patients

Por Comen, Elizabeth, Wojnarowicz, Paulina, Seshan, Venkatraman E, Shah, Riddhi, Coker, Courtney, Norton, Larry, Benezra, Robert
Publicado no NPJ Breast Cancer (2016)

Unraveling the clinicopathological features driving the emergence of ESR1 mutations in metastatic breast cancer

Por Kuang, Yanan, Siddiqui, Bilal, Hu, Jiani, Pun, Matthew, Cornwell, MacIntosh, Buchwalter, Gilles, Hughes, Melissa E., Wagle, Nikhil, Kirschmeier, Paul, Jänne, Pasi A., Paweletz, Cloud P., Lin, Nancy U., Krop, Ian E., Barry, William T., Winer, Eric P., Brown, Myles, Jeselsohn, Rinath
Publicado no NPJ Breast Cancer (2018)

Correlating nuclear morphometric patterns with estrogen receptor status in breast cancer pathologic specimens

Por Rawat, Rishi R., Ruderman, Daniel, Macklin, Paul, Rimm, David L., Agus, David B.
Publicado no NPJ Breast Cancer (2018)

Germline variants associated with leukocyte genes predict tumor recurrence in breast cancer patients

Por Milanese, Jean-Sébastien, Tibiche, Chabane, Zou, Jinfeng, Meng, Zhigang, Nantel, Andre, Drouin, Simon, Marcotte, Richard, Wang, Edwin
Publicado no NPJ Precis Oncol (2019)

Mendelian randomization analyses of genetically predicted circulating levels of cytokines with risk of breast cancer

Por Li, Shen, Xu, Yan, Zhang, Yao, Nie, Lili, Ma, Zhihua, Ma, Ling, Fang, Xiaoyu, Ma, Xiangyu
Publicado no NPJ Precis Oncol (2020)

Preoperative magnetic resonance imaging use and oncologic outcomes in premenopausal breast cancer patients

Por Zeng, Zexian, Amin, Amanda, Roy, Ankita, Pulliam, Natalie E., Karavites, Lindsey C., Espino, Sasa, Helenowski, Irene, Li, Xiaoyu, Luo, Yuan, Khan, Seema A.
Publicado no NPJ Breast Cancer (2020)

Molecular stratification of early breast cancer identifies drug targets to drive stratified medicine

Por Bayani, Jane, Yao, Cindy Q., Quintayo, Mary Anne, Yan, Fu, Haider, Syed, D’Costa, Alister, Brookes, Cassandra L., van de Velde, Cornelis J. H., Hasenburg, Annette, Kieback, Dirk G., Markopoulos, Christos, Dirix, Luc, Seynaeve, Caroline, Rea, Daniel, Boutros, Paul C., Bartlett, John M. S.
Publicado no NPJ Breast Cancer (2017)

Inherited breast cancer predisposition in Asians: multigene panel testing outcomes from Singapore

Por Wong, Edward S Y, Shekar, Sandhya, Met-Domestici, Marie, Chan, Claire, Sze, Melody, Yap, Yoon Sim, Rozen, Steven G, Tan, Min-Han, Ang, Peter, Ngeow, Joanne, Lee, Ann S G
Publicado no NPJ Genom Med (2016)

Prognostic characteristics in hormone receptor-positive advanced breast cancer and characterization of abemaciclib efficacy

Por Di Leo, Angelo, O’Shaughnessy, Joyce, Sledge, George W., Martin, Miguel, Lin, Yong, Frenzel, Martin, Hardebeck, Molly C., Smith, Ian C., Llombart-Cussac, Antonio, Goetz, Matthew P., Johnston, Stephen
Publicado no NPJ Breast Cancer (2018)

Oncotype DX recurrence score implications for disparities in chemotherapy and breast cancer mortality in Georgia

Por Collin, Lindsay J., Yan, Ming, Jiang, Renjian, Ward, Kevin C., Crawford, Brittany, Torres, Mylin A., Gogineni, Keerthi, Subhedar, Preeti D., Puvanesarajah, Samantha, Gaudet, Mia M., McCullough, Lauren E.
Publicado no NPJ Breast Cancer (2019)

Development and implementation of the SUM breast cancer cell line functional genomics knowledge base

Por Ethier, Stephen P., Guest, Stephen T., Garrett-Mayer, Elizabeth, Armeson, Kent, Wilson, Robert C., Duchinski, Kathryn, Couch, Daniel, Gray, Joe W., Kappler, Christiana
Publicado no NPJ Breast Cancer (2020)

NF1 deficiency correlates with estrogen receptor signaling and diminished survival in breast cancer

Por Dischinger, Patrick S., Tovar, Elizabeth A., Essenburg, Curt J., Madaj, Zachary B., Gardner, Eve E., Callaghan, Megan E., Turner, Ashley N., Challa, Anil K., Kempston, Tristan, Eagleson, Bryn, Kesterson, Robert A., Bronson, Roderick T., Bowman, Megan J., Graveel, Carrie R., Steensma, Matthew R.
Publicado no NPJ Breast Cancer (2018)

Characterization of four subtypes in morphologically normal tissue excised proximal and distal to breast cancer

Por Gadaleta, Emanuela, Fourgoux, Pauline, Pirró, Stefano, Thorn, Graeme J., Nelan, Rachel, Ironside, Alastair, Rajeeve, Vinothini, Cutillas, Pedro R., Lobley, Anna E., Wang, Jun, Gea, Esteban, Ross-Adams, Helen, Bessant, Conrad, Lemoine, Nicholas R., Jones, Louise J., Chelala, Claude
Publicado no NPJ Breast Cancer (2020)

Ethnic and biological differences in the association between physical activity and survival after breast cancer

Por Cao, Yunfeng, Baumgartner, Kathy B., Visvanathan, Kala, Boone, Stephanie D., Baumgartner, Richard N., Connor, Avonne E.
Publicado no NPJ Breast Cancer (2020)

Ancestry-associated transcriptomic profiles of breast cancer in patients of African, Arab, and European ancestry

Por Roelands, Jessica, Mall, Raghvendra, Almeer, Hossam, Thomas, Remy, Mohamed, Mahmoud G., Bedri, Shahinaz, Al-Bader, Salha Bujassoum, Junejo, Kulsoom, Ziv, Elad, Sayaman, Rosalyn W., Kuppen, Peter J. K., Bedognetti, Davide, Hendrickx, Wouter, Decock, Julie
Publicado no NPJ Breast Cancer (2021)

Association between the nucleosome footprint of plasma DNA and neoadjuvant chemotherapy response for breast cancer

Por Yang, Xu, Cai, Geng-Xi, Han, Bo-Wei, Guo, Zhi-Wei, Wu, Ying-Song, Lyu, Xiaoming, Huang, Li-Min, Zhang, Yuan-Bin, Li, Xin, Ye, Guo-Lin, Yang, Xue-Xi
Publicado no NPJ Breast Cancer (2021)

21-Gene assay as predictor of chemotherapy benefit in HER2-negative breast cancer

Por Geyer, Charles E., Tang, Gong, Mamounas, Eleftherios P., Rastogi, Priya, Paik, Soonmyung, Shak, Steven, Baehner, Frederick L., Crager, Michael, Wickerham, D. Lawrence, Costantino, Joseph P., Wolmark, Norman
Publicado no NPJ Breast Cancer (2018)